A drug already approved by the FDA to treat menopause symptoms may also help prevent invasive breast cancer, according to new findings from a multi-center phase 2 clinical trial led by Northwestern ...

Breast lesions encompass an array of benign and pre-malignant conditions with significant implications for patient management and cancer prevention. Among these, atypical ductal hyperplasia (ADH) is a ...

DEAR DR. ROACH: I am 70. Due to breast cancer history in my family and a diagnosis of atypical ductal hyperplasia in a lump that was removed, I get MRIs with and without imaging agents annually. Do I ...

The Breast Cancer Risk Clinic at Huntsman Cancer Institute is for women who may have a higher chance of breast or ovarian cancer due to genetic mutations or a family history of cancer. The purpose of ...

Ductal carcinoma in situ (DCIS) of the breast develops into invasive breast cancer (IBC) in approximately 50 percent of women if left untreated, with the risk extending over more than forty years, ...

Duavee slowed cell growth in women with non-invasive breast cancer Already approved for menopausal symptoms, Duavee didn’t affect quality of life in participants May offer safe option for women with ...